Expectations trend
FY2028 · fiscal year ending 2028-03-31 · fmp
ePlus, Inc. (PLUS)
NASDAQInformation TechnologySoftware - ApplicationSnapshot 2026-11-04
$90.47+0.69%
Close 2026-11-04 · 1-day change
NASDAQInformation TechnologySoftware - ApplicationSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
5.96 → 5.84 EPS · FY ending Mar 31, 2028 · 2 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 2 to 2; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for PLUS yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Expand AI consulting services to capture emerging market opportunities | A supporting condition in ePlus, Inc.'s published investment case. The stated target is sustain growth in AI consulting segment. | Improving | AI consulting growth stalls or declines over next year | Qualitative condition This condition has no defined numerical measure. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2028 · fiscal year ending 2028-03-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
PLUS is a growth-oriented business with a recent record of strong revenue and profit expansion, rather than a clear turnaround or stable compounder. Its long-term thesis is intact, though the evidence is mixed and confidence is medium.
The valuation evidence describes PLUS as cheap versus peers, while the expectations gap is negative, suggesting expectations are not especially demanding. The pricing assessment is marked justified, but it does not remove concerns about fragile earnings quality or elevated risk.
Fiscal 2026 net sales grew 22.1% and adjusted EBITDA, a measure of operating profit before certain costs, rose 49.5%. Management reaffirmed fiscal 2027 guidance for mid-single-digit growth in net sales, gross profit, and adjusted EBITDA, a slower pace than the latest fiscal year. Near term, guidance execution remains the main risk, alongside erratic earnings surprises and recent elevated risk.
The multi-year view depends on PLUS delivering its reaffirmed guidance and sustaining growth while earnings quality remains fragile. A guidance cut would weaken the case; easier interest rates or steadier results and guidance from major technology peers could improve the sector backdrop.
Over the next 1 to 3 years, PLUS has a supportive growth record and a valuation described as cheap versus peers, but the thesis depends on reliable execution as growth moderates and risk stays elevated. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A supporting condition in ePlus, Inc.'s published investment case. The stated target is >= $410.8 million cash; dividend >= $0.27 per share. |
| Intact |
| cash falls below $389M or dividend cut below $0.27 |
Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Maintain gross margin between 19% and 21% next quarter | Profit margins remain strong with gross margin guidance raised to 19-21%. | Intact | gross margin falls below 19% next quarter | Gross margin: 23.31% FY2027-Q1; GAAP. Published target: 19% to 21%. The stored target says 2026-Q4; this source reports FY2027-Q1. Fiscal/calendar alignment needs review. Aug 4, 202623.313198 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Drive double-digit revenue growth to at least $2.44B in fiscal 2026 | A primary condition in ePlus, Inc.'s published investment case. The stated target is >= $2.44 billion. | Intact | revenue falls below $2.0 billion in FY26 | Revenue: $649.113M FY2027-Q1; GAAP. Published target: >= $2.44 billion. Annual target cannot be compared with a quarterly or TTM observation. Aug 4, 2026649,113,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$5.80 → $5.84 · observed estimates
$2.69B → $2.68B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $5.80 | $2,693,650,000 | 2 / 2 |
| 2026-07-25 | $5.80 | $2,693,650,000 | 2 / 2 |
| 2026-07-26 | $5.80 | $2,693,650,000 | 2 / 2 |
| 2026-07-27 | $5.80 | $2,693,650,000 | 2 / 2 |
| 2026-07-28 | $5.80 | $2,693,650,000 | 2 / 2 |
| 2026-07-29 | $5.80 | $2,693,650,000 | 2 / 2 |
| 2026-07-30 | $5.85 | $2,693,650,000 | 2 / 2 |
| 2026-07-31 | $5.85 | $2,693,650,000 | 2 / 2 |
| 2026-08-01 | $5.85 | $2,693,650,000 | 2 / 2 |
| 2026-08-02 | $5.80 | $2,693,650,000 | 2 / 2 |
| 2026-08-03 | $5.85 | $2,693,650,000 | 2 / 2 |
| 2026-08-04 | $5.85 | $2,693,650,000 | 2 / 2 |
| 2026-08-05 | $5.85 | $2,693,650,000 | 2 / 2 |
| 2026-08-06 | $5.85 | $2,693,650,000 | 2 / 2 |
| 2026-08-07 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-08-08 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-08-09 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-08-10 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-08-12 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-08-13 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-08-14 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-08-15 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-08-16 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-08-17 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-08-18 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-08-19 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-08-20 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-08-21 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-08-22 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-08-23 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-08-24 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-08-25 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-08-26 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-08-27 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-08-28 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-08-29 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-08-30 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-08-31 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-09-01 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-09-02 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-09-03 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-09-04 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-09-05 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-09-06 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-09-07 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-09-08 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-09-09 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-09-10 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-09-11 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-09-12 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-09-13 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-09-14 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-09-15 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-09-16 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-09-17 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-09-18 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-09-19 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-09-20 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-09-21 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-09-22 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-09-23 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-09-24 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-09-25 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-09-26 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-09-27 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-09-28 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-09-29 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-09-30 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-10-01 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-10-02 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-10-03 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-10-04 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-10-05 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-10-06 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-10-07 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-10-08 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-10-09 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-10-10 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-10-11 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-10-12 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-10-13 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-10-14 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-10-15 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-10-16 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-10-17 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-10-18 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-10-19 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-10-20 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-10-21 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-10-22 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-10-23 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-10-24 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-10-25 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-10-26 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-10-27 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-10-28 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-10-29 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-10-30 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-10-31 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-11-01 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-11-02 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-11-03 | $5.96 | $2,681,800,000 | 2 / 2 |
| 2026-11-04 | $5.84 | $2,681,800,000 | 2 / 2 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 1 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Nov 5, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.